COSMO — Farmacosmo SpA Balance Sheet
0.000.00%
Last trade - 00:00- €31.83m
- €31.61m
- €71.21m
- 19
- 50
- 41
- 27
Annual balance sheet for Farmacosmo SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.942 | 2.06 | 1.41 | 6.85 | — |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2.51 | 4.62 | 5.71 | 10.2 | — |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 3.98 | 7.66 | 9.26 | 21.8 | — |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.195 | 0.193 | 0.296 | 0.483 | — |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Total Assets | 4.78 | 8.71 | 10.8 | 39.2 | — |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4.25 | 7.95 | 8.98 | 18.9 | — |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 4.4 | 8.15 | 9.8 | 21.8 | — |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 0.381 | 0.553 | 0.967 | 17.4 | — |
| Total Liabilities & Shareholders' Equity | 4.78 | 8.71 | 10.8 | 39.2 | — |
| Total Common Shares Outstanding |